SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0000950142-24-001034
Filing Date
2024-04-15
Accepted
2024-04-15 07:57:22
Documents
1
Effectiveness Date
2024-04-15

Document Format Files

Seq Description Document Type Size
1 FORM 15-12G eh240468323_1512g.htm 15-12G 11990
  Complete submission text file 0000950142-24-001034.txt   13047
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-38853 | Film No.: 24843132
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)